Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000926617-17-000008
Filing Date
2017-02-15
Accepted
2017-02-15 17:08:35
Documents
1
Period of Report
2017-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 5209
  Complete submission text file 0000926617-17-000008.txt   6845
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ALBANY MOLECULAR RESEARCH, INC. 26 CORPORATE CIRCLE ALBANY NY 12212-5098
Business Address
Jordan Veronica GH (Reporting) CIK: 0001381123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 17615494